Condition
Gastrectomy for Gastric Cancer clinical trials and research
As of November 12, 2026, Find a Trial lists 5 Gastrectomy for Gastric Cancer clinical trials that are recruiting, at sites in 5 countries (most in Ukraine (2), Italy (1), South Korea (1)). By phase: Phase 2/3 (1), Phase 3 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 5Clinical trials
- 5Countries
Newest Gastrectomy for Gastric Cancer clinical trials
| Study | Phase | Where | Status | Registered |
|---|---|---|---|---|
| AI-guided reoperation decisions for bleeding after stomach cancer surgery | — | Hangzhou, Zhejiang | Recruiting | Apr 13, 2026 |
| Enhanced recovery (ERAS) after minimally invasive stomach cancer surgery | — | Busan and 9 other locations | Recruiting | May 22, 2025 |
| Using indocyanine green to improve lymph node removal in gastric cancer surgery | Phase 3 | Kyiv and 1 other locations | Recruiting | Jan 1, 2025 |
| Assessing lymph node removal quality during minimally invasive gastric cancer surgery | — | Cremona, CR and 7 other locations | Recruiting | Jun 20, 2024 |
| Total neoadjuvant chemotherapy for advanced gastric and gastroesophageal cancer | Phase 2/3 | Vilnius and 1 other locations | Recruiting | Sep 8, 2023 |
All recruiting trials (5)
-
AI-guided reoperation decisions for bleeding after stomach cancer surgery
This project will test whether an AI model can predict serious postoperative bleeding and help doctors decide if and when to reoperate for adults after radical gastrectomy for gastric cancer.
-
Enhanced recovery (ERAS) after minimally invasive stomach cancer surgery
This project tests whether an enhanced recovery (ERAS) program helps people recover faster and leave the hospital sooner after minimally invasive stomach cancer surgery.
-
Using indocyanine green to improve lymph node removal in gastric cancer surgery
This study is testing if a special dye called indocyanine green can help surgeons find and remove more lymph nodes during gastric cancer surgery.
-
Assessing lymph node removal quality during minimally invasive gastric cancer surgery
This study is testing a new scoring system to see if it can help doctors better assess lymph node removal during minimally invasive surgery for stomach cancer and improve patient outcomes.
-
Total neoadjuvant chemotherapy for advanced gastric and gastroesophageal cancer
This study is testing two different chemotherapy plans for people with advanced stomach cancer to see which one helps them better tolerate treatment and successfully have surgery.
Related topics
Quick answers
How many Gastrectomy for Gastric Cancer clinical trials are recruiting right now?
5, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 5 countries. The most sites are in Ukraine (2 trials), Italy (1 trial), South Korea (1 trial), China (1 trial), Lithuania (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 2/3: 1, Phase 3: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.